Nuvation Bio Newsroom

Nuvation Bio Is Maintained at Outperform by RBC Capital

Dow JonesNov 7 12:27 ET

Nuvation Bio Analyst Ratings

BenzingaNov 7 12:17 ET

TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating

Moomoo NewsNov 7 08:39 ET

RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $6

Moomoo NewsNov 7 07:31 ET

TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating

Moomoo NewsNov 6 18:31 ET

TD Cowen Sticks to Its Buy Rating for Nuvation Bio (NUVB)

TipRanksNov 6 17:59 ET

Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush

Dow JonesOct 22 11:00 ET

Jefferies Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 16 08:31 ET

Nuvation Bio Analyst Ratings

BenzingaSep 16 07:06 ET

H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $7

Moomoo NewsSep 16 06:31 ET

Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsSep 11 08:33 ET

Jefferies Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 11 08:33 ET

Nuvation Bio Analyst Ratings

BenzingaAug 6 08:49 ET

RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsAug 6 07:39 ET

Nuvation Bio (NUVB) Gets a Buy From RBC Capital

TipRanksAug 6 06:53 ET

TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating

Moomoo NewsAug 5 14:31 ET

Nuvation Bio Earns Buy Rating on Robust Pipeline and Strategic Focus

TipRanksAug 5 13:47 ET

BTIG Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsJul 24 07:39 ET

Analysts' Top Healthcare Picks: Intuitive Surgical (ISRG), Nuvation Bio (NUVB)

TipRanksJul 19 06:15 ET

Buy Rating Affirmed for Nuvation Bio Amid Promising Taletrectinib Trials and Orphan Drug Designation

TipRanksJul 17 12:41 ET